Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avitene and Sapylin for Seroma Reduction in Breast Cancer
NCT02158299Phase 4Unknown
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Oct 2013
- Primary completion
- Nov 2014
- Modality
- Device-based Delivery, Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of avitene, streptococcus pyogenes preparation in Seroma, sponsored by Sun Yat-sen Memorial Hospital. Status: unknown.
02
Drugs
avitenestreptococcus pyogenes preparation
03
Conditions
Seroma
Beyond the preview
Go deeper on NCT02158299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02158299.